Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
about
Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactionsMucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxinsHeat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodiesInduction of mosquitocidal activity in mice immunized with Anopheles gambiae midgut cDNAProphylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvantOral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.Physical characterization of the "immunosignaturing effect"The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigensA Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin.Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.Single Chain Variable Fragments Produced in Escherichia coli against Heat-Labile and Heat-Stable Toxins from Enterotoxigenic E. coli.Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors.Lipopolysaccharide 3-deoxy-D-manno-octulosonic acid (Kdo) core determines bacterial association of secreted toxinsToll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse moPromotion of colonization and virulence by cholera toxin is dependent on neutrophils.Promising particle-based vaccines in cancer therapy.Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesDifferent assay conditions for detecting the production and release of heat-labile and heat-stable toxins in enterotoxigenic Escherichia coli isolates.Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae.Production, characterization, and application of antibodies against heat-labile type-I toxin for detection of enterotoxigenic Escherichia coli.
P2860
Q24337629-2B1497CC-87A4-40E9-8274-67433725A9FFQ28187952-25016AD4-A976-4240-B381-B0707F7969C8Q30363424-9CD4C323-187C-4658-A4BE-7613DD6B89E3Q30427618-4424E946-E33B-4710-9609-6B1FF4ABAEF2Q30903583-6E269704-79C6-47DA-8657-0A0B818A7E1CQ33676552-13EEA293-751D-4F0E-B0B5-35C7AE810444Q33741147-C3952E05-F30B-4055-867C-BBE6ADCCDE75Q33883273-3EDC5089-A5B6-4210-ADC3-B6058508747CQ34248453-50747E72-81E9-4B11-93D3-C2A5A51535D9Q34270342-631DF32B-9DBE-4E86-B6F0-E56CEE98C63CQ34708547-20A82F59-022B-4AE0-A70C-AD51391CBC51Q34784973-4CD3AEAA-C63B-43BA-BF49-E937A05BB9A3Q34998726-A4874203-2AFF-4C6F-AFA7-BCC6B30D57B2Q35191960-E6502CE3-1017-45DB-A2B8-48799CCDE6A3Q35192203-D97221E4-E964-4390-A9E4-89B1EADDC44EQ35685836-6EE266BE-6BFF-4C68-B9FD-455D0370DB0AQ36030835-3C97B0DC-3BDB-4B1E-8AE9-DAAA740F3A44Q36475473-C6B7E8AF-ADAD-4844-9300-7623CA6A9FDFQ36911461-370A0388-1BE1-46DE-B30A-87B21CF30C1AQ37123707-F74C50F7-0E04-45D9-80FE-2B0456DFFE87Q37259642-57A7F183-0D4E-4167-9C77-5E67356EA2A8Q37264192-BB61D1F6-1F6A-4C2E-A66A-C3339D9B68A7Q37415995-002B95C2-3C2D-4267-95F8-66A097A58FC5Q42061615-33705424-D580-4400-9387-6D2AB15821A4Q50073701-798FBD96-289D-4BF4-AD25-0CC4257AADEE
P2860
Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Differential biological and ad ...... at-labile enterotoxin hybrids.
@ast
Differential biological and ad ...... at-labile enterotoxin hybrids.
@en
Differential biological and ad ...... at-labile enterotoxin hybrids.
@nl
type
label
Differential biological and ad ...... at-labile enterotoxin hybrids.
@ast
Differential biological and ad ...... at-labile enterotoxin hybrids.
@en
Differential biological and ad ...... at-labile enterotoxin hybrids.
@nl
prefLabel
Differential biological and ad ...... at-labile enterotoxin hybrids.
@ast
Differential biological and ad ...... at-labile enterotoxin hybrids.
@en
Differential biological and ad ...... at-labile enterotoxin hybrids.
@nl
P2860
P1476
Differential biological and ad ...... at-labile enterotoxin hybrids.
@en
P2093
C C Bowman
J D Clements
P2860
P304
P356
10.1128/IAI.69.3.1528-1535.2001
P407
P577
2001-03-01T00:00:00Z